Navigation Links
Pharmos Corporation Announces Board and Management Changes
Date:1/3/2008

Robert F. Johnston Named Executive Chairman of the Board

S. Colin Neill Named President

ISELIN, N.J., Jan. 3 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS) announced today certain changes in its Board of Directors and Management, effective immediately.

Board Changes

Robert F. Johnston has been elected to the Board as Executive Chairman.

Haim Aviv, Ph.D., David Schlachet and Mony Ben Dor have retired from the Board.

The Pharmos Board now consists of seven directors -- Robert F. Johnston, Chairman, Anthony B. Evnin (Venrock), Charles W. Newhall, III (New Enterprise Associates), Srinivas Akkaraju, M.D., Ph.D. (Panorama Capital), Abraham Sartani, M.D. (Recordati S.p.A.), Lloyd I. Miller, III and Elkan Gamzu, Ph.D.

Management Changes

The Pharmos Board designated Mr. Robert F. Johnston to serve as Executive Chairman of the Board and Mr. S. Colin Neill to serve as President, in addition to his current roles as Chief Financial Officer, Treasurer and Secretary.

Elkan Gamzu Ph.D., who has been Chief Executive Officer, retires from that position and will remain on the Board.

Robert F. Johnston

Robert F. Johnston, a venture capitalist, is President of Johnston Associates which he founded in 1968 to provide financing for emerging companies in the biotechnology and healthcare fields.

Mr. Johnston was a founder and Chairman of Vela Pharmaceuticals, Inc., which merged into Pharmos in late 2006, and has founded numerous public companies including Sepracor, Cytogen, I-STAT, Ecogen, Genex and Envirogen. He also played an active and key role in the early formations of private companies such as Sonomed, Immunicon, PharmaStem (formerly Bioc
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
2. Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
3. Pharmos Corporation Reports 2007 Third Quarter Results
4. Pharmos Issues Letter to Shareholders
5. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
6. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
7. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
10. FMC Corporation and Pronova BioPharma Announce Agreement To Develop New Alginate-Based Capsule Products
11. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Stem cell-enriched autologous fat enables sustainable breast augmentation ... the media: For years a French company has been ... cause cancer. More than 100,000 women worldwide must now ... or carrying a "time bomb" in their bodies. Stem ...
... Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it will ... the Windsor Room of the Sir Francis Drake Hotel as ... emerging biotech companies held over 3 days this week in ... attendees are expected to be listening to presentations by up ...
... SEATTLE, Jan. 10, 2012  Omeros Corporation (NASDAQ: OMER ... selectively with each of GPR25, GPR32, GPR80, GPR135 and MAS1, ... unlocked by Omeros to 23, representing 30 percent of the ... unlocked by Omeros for drug development equals half of the ...
Cached Biology Technology:Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 2Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 4Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 5
(Date:4/15/2014)... research published in the March/April 2014 issue of ... shows whey protein, either as a supplement combined ... or weight-maintenance diet, may provide men and women benefits ... 14 randomized controlled trials with a total of 626 ... that used whey protein to replace calories in the ...
(Date:4/14/2014)... Rican climate over the past three decades have caused ... territory,s national animal. UCLA biologists have found that not ... call has also become shorter and higher pitched. ... of integrative biology and physiology and of ecology and ... the study examined 170 male coqui frogs ( Eleutherodactylus ...
(Date:4/14/2014)... the International Space Station inside the Dragon capsule ... in-orbit food production capabilities in more ways than ... for granted, fresh food. , NASA,s Veg-01 experiment ... and performance of a new expandable plant growth ... investigation will focus on the growth and development ...
Breaking Biology News(10 mins):New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3Climate change a likely culprit in coqui frog's altered calls, say UCLA biologists 2Veggie will expand fresh food production on space station 2
... -- Dangerous disease often spreads faster than it takes ... researchers at Kansas State University have developed a test ... Sanjeev Narayanan, assistant professor, and Greg Peterson, research ... pathobiology, use a device called a DNA spotted microarray ...
... Ackermann and Wolf-Dietrich Hardt, in collaboration with Michael Doebeli ... have been able to describe how random molecular processes ... a self-destructive act to generate a greater common good, ... Survival strategy The biologists investigated this ...
... relapse after renewed drug administration are typical behavioral patterns ... the brain,s reward center are directly responsible for this. ... the Institute of Mental Health (ZI) in Mannheim, the ... University of Geneva, Switzerland, in the latest issue of ...
Cached Biology News:Rapid test for pathogens developed by K-State researchers 2ETH Zurich study on salmonella self-destruction 2ETH Zurich study on salmonella self-destruction 3Cocaine: How addiction develops 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
... Immunogen: Peptide ... encompassing the human, mouse, and ... Accession Number: NM_000314 ... Routinely evaluated by immunoblot. ...
Mouse monoclonal [MN-8C4] to zona radiata ( Abpromise for all tested applications). Antigen: Purified eggshell proteins (zona radiata proteins and small amounts of zona pellucida proteins) from ...
Biology Products: